AI assistant
Sending…
BICYCLE THERAPEUTICS PLC — Director's Dealing 2020
Apr 27, 2020
32777_dirs_2020-04-27_e0379593-6a42-4169-bf26-b9f9fe0f6f81.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2019-06-28
Reporting Person: Lee Kevin (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-28 | Stock Option (Right to Buy) | $14.00 | A | 506252 | Acquired | 2029-06-28 | Ordinary Shares (506252) | Direct |
Footnotes
F1: The original Form 4 inadvertently listed the incorrect date of earliest transaction, transaction date and expiration date. This Form 4 amendment is being filed to accurately reflect the appropriates dates.
F2: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant.
More from BICYCLE THERAPEUTICS PLC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 20
Director's Dealing
2026
Mar 25
Annual Report
2026
Mar 17
Board/Management Information
2026
Mar 17
Major Shareholding Notification
2026
Feb 11
Director's Dealing
2026
Feb 4
Board/Management Information
2026
Feb 3